Human T lymphocyte activation in the presence of acute myelogenous leukaemia blasts: Studies of allostimulated interferon-γ secretion

Cancer Immunology Immunotherapy

Volumn 43, Issue 5, 1997, Pages 275-282

  Bruserud, Øystein ^a,b   Mentzoni, Laila ^a   Foss, Brynjar ^b   Bergheim, Jann ^a   Berentsen, Sigbjørn ^a   Nesthus, Ingerid ^a  

^a UNIVERSITY OF BERGEN   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

acute myelogenous leukaemia; interferon ; T lymphocytes

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CYTOKINE; GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ARTICLE; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN CELL; LYMPHOCYTE ACTIVATION; MALE; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0030474319     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002620050334     Document Type: Article

References (44)

1. Asano Y, Okamura S, Shibuya T, Harada M, Niho Y (1988) Growth of clonogenic myeloblastic leukemia cells in the presence of human recombinant erythropoietin in addition to various human recombinant hematopoietic growth factors. Blood 72:1682
2. Beatty PG, Anasetti C, Hansen JA et al. (1993) Marrow transplantation from unrelated donors for treatment of hematological malignancies: effects of mismatching for one HLA locus. Blood 81:249
3. Bejanaro M-T, deWaal Malefyt R, Bigler N et al. (1992) Interleukin 10 inhibits allogeneic proliferative and cytotoxic T cell responses generated in primary mixed lymphocyte cultures. Int Immunol 4:1389
4. + LAK cells as consolidative immunotherapy after autologous bone marrow transplantation for acute myeloid leukemia. Blood 80 [Suppl]:1320a
5. Borger P, Kauffman HF, Postma DS, Vellenga E (1996) IL7 differentially modulates the expression of IFNγ and IL4 in activated human T lymphocytes by transcriptional and posttranscriptional mechanisms. J Immunol 156:1333
6. Brach M, Stone R, Kufe D (1991) CSFs in combination with cytosine arabinoside, an inhibitor of DNA synthesis: potential strategies for the treatment of myeloid disorders. Biotechnol Ther 2:269
7. + TCRαβ + T-cell clones derived early after allogeneic bone marrow transplantation. Eur J Haematol 51:73
8. Bruserud Ø, Nesthus I, Bühring H-J, Pawelec G (1995) Cytokine modulation of interleukin I and tumour necrosis factor-αsecretion from acute myelogenous leukaemia blast cells in vitro. Leukaemia Res 19:15
9. Bruserud Ø, Gjertsen BT, Brustugun OT, Bassøe C-F, Nesthus I, Bühring HJ, Pawelec G (1995) Effects of interleukin 10 on blast cells derived from patients with acute myelogenous leukemia. Leukemia 9:1910
10. Bruserud Ø, Pawelec G (1996) Human T lymphocyte activation in the presence of acute myelogenous leukemia blasts; studies of polyclonal T cells and T lymphocyte clones derived early after allogeneic bone marrow transplantation. Cancer Immunol Immunother 42:133
11. Bruserud Ø (1996) Effects of interleukin 13 on cytokine secretion by acute myelogenous leukemia blasts. Leukemia 10:1497
12. Butturini A, Santucci MA, Gale RP, Perocco P, Tura S (1990) GM-CSF incubation prior to treatment with cytarabine or doxorubicine enhances drug activity against AML cells in vitro: a model for leukemia chemotherapy. Leukemia Res 14:743
13. Cozzolino F, Rubartelli A, Aldinucci D, Sitia R, Torcia M, Shaw A, diGuglielmo R (1989) Interleukin 1 as an autocrine growth factor for acute myeloid leukaemia cells. Proc Natl Acad Sci USA 86:2369
14. Decker T, Flohr T, Trautmann P et al. (1995) Role of accessory cells in cytokine production by T cells in chronic B-cell lymphocytic leukemia. Blood 86:1115
15. Delforge A, Vandenplas B, Lagneaux L, Loos M, Bron D, Debusscher L, Stryckmans P (1990) Influence of recombinant alpha and gamma interferons on the in vitro proliferation of myeloid and leukemic progenitors. Fur J Haematol 44:307
16. Demetri GD, Griffin JD (1991) Granulocyte colony-stimulating factor and its receptor. Blood 78:2791
17. Dinarello CA (1991) Interleukin I and interleukin 1 antagonism. Blood 77:1627
18. Egner W, Andreesen R, Hart DNJ (1993) Allostimulatory cells in fresh human blood. Transplantation 56:945
19. Gambercorti-Passerini C, Grignani F, Arienti F, Pandolfi PP, Pelicci PG, Parmiani G (1993) Human CD4 lymphocytes specifically recognize a peptide representing the fusion region on the hybride protein pml/RARalpha present in acute promyelocytic leukemia cells. Blood 81:1369
20. Giralt S, Hester J, Huh Y, Hirsch-Ginsberg C, Rondon G, Seong D, Lee M, Gajewski J, Besien KV, Khouri I, Mehra R, Przepiorka D, Körbling M, Talpaz M, Kantarjian H, Fischer H, Deisseroth A, Champlin R (1995) CD8-depleted donor lymphocyte infusion as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation. Blood 86:4337
21. Hamon MD, Prentice HG, Gottlieb DJ et al. (1993) Immunotherapy with interleukin 2 after ABMT in AML. Bone Marrow Transplant 11:399
22. Hessner MJ, Endean DJ, Casper JT, Horowitz MM, Keever-Taylor CA, Roth M, Flomenberg N, Drobyski WR (1995) Use of unrelated marrow grafts compensates for reduced graft-versus-leukemia reactivity after T cell depleted allogeneic marrow transplantation for chronic myelogenous leukemia. Blood 86:3987
23. Lecchi M, Lovisone E, Genetta C, Peruccio D, Resegotti L, Richiardi P (1989) γ IFN induces a differential expression of HLA-DR DQ and DP antigens on peripheral blood myeloid leukemic blasts at various stages of differentiation. Leukemia Res 13:221
24. Lemoli RM, Gulati SC, Strife A, Lambek C, Perez A, Clarkson BD (1991) Proliferative response of human acute myeloid leukemia cells and normal marrow enriched progenitor cells to human recombinant growth factors IL3, GM-CSF and G-CSF alone and in combination. Leukemia 5:386
25. Liu Z, Sun Y-K, Xi Y-P, Maffei A, Reed E, Harris P, Suciu-Foca N (1993) Contribution of direct and indirect recognition pathways to T cell alloreactivity. J Exp Med 177:1643
26. McGlave PB, Haake RJ, Bostrom BC, Brunning R, Hurd DD, Kim TH, Nesbit ME, Vercellotti GM, Weisdorf D, Woods WG, Ramsay NKC, Kersey JH (1988) Allogeneic hone marrow transplantation for acute nonlymphoblastic leukemia in first remission. Blood 72:1512
27. Meyer RJ, Davis RB, Schiffer CA, Berg DT, Powell BL, Schulman P, Omura GA, Moore JO, McIntyre OR, Frei III E (1994) Intensive postremission therapy in adults with acute myeloid leukemia. N Engl J Med 331:896
28. Moen T (1982) Primed lymphocyte typing (PLT): application in typing for HLA-D locus determinants. In: Ferrone S, Solheim BG (eds) HLA typing methodology and clinical aspects. II. CRC, Boca Raton, Fla, pp 71-81
29. Murohashi I, Hoang T (1991) Interferon-γ enhances growth factor-dependent proliferation of clonogenic cells in acute myeloblastic leukemia. Blood 78:1085
30. Nara N (1993) Combined effect of interferon-γ and tumor necrosis factor-αcausing suppression of leukemic blast progenitors in acute myeloblastic leukemia. Leukemia Lymphoma 10:201
31. Nara N, McCulloch EA (1985) The proliferation in suspension of the progenitors of the blast cells in acute myeloblastic leukemia. Blood 65:1484
32. Niederwieser D, Grassegger A, Auböck J, Herold M, Nachbaur D, Rosenmayr A, Gächter A, Nussbaumer W, Gaggi S, Ritter M, Huber C (1993) Correlation of minor histocompatibility antigen-specific cytotoxic T lymphocytes with graft-versus-host disease status and analyses of tissue distribution of their target antigens. Blood 81:2200
33. Pawelec G (1994) Immune surveilance in leukemia: rationale for immunotherapy. Hematol Rev 8:123
34. Rambaldi A, Torcia M, Bettoni S, Vannier E, Barbui T, Shaw AR, Dinarello CA, Cozzolino F (1991) Modulation of cell proliferation and cytokine production by interleukin I receptor antagonist and lack of its expression by leukemic cells. Blood 78:3248
35. Reizenstein P (1990) Adjuvant immonotherapy with BCG of acute myeloid leukemia: a 15-years follow up. Br J Haematol 75:288
36. Russel NH (1992) Autocrine growth factors and leukemic hematopoiesis. Blood Rev 6:149
37. Schwartz RH (1992) Costimulution of T lymphocytes: the role of CD28, CTLA-4 and B7/BB1 in interleukin 2 production and immunotherapy. Cell 71:1065
38. Sissolak G, Hoffbrand AV, Mehta AB, Ganeshaguru K (1992) Effects of interferon-alpha (IFN) on the expression of interleukin 1β (IL1). Interleukin 6 (IL 6), granulocyte-macrophage colony stimulating factor (GM-CSF) and tumor necrosis factor-αin acute myeloid leukemia (AML) blasts. Leukemia 6:1155
39. Stone RM, Spriggs DR, Arthur KA, Mayer RJ, Griffin J, Kufe DW (1993) Recombinant human gamma interferon administered by continuous intravenous infusion in acute myelogenous leukemia and myelodysplastic syndromes. Am J Clin Oncol 16:159
40. Talpaz, M, Kantarjian HM, Kurzrock R, Guttermann J (1988) Therapy of chronic myelogenous leukemia: chemotherapy and interferons. Semin Haematol 25:62
41. Thomas R, Davis LS, Lipsky PE (1993) Comparative accessory cell function in human peripheral blood dendritic cells and monocytes. J. Immunol 151:6840
42. Toungouz M, Denys C, Groothe DD, Andrien M, Dupont E (1996) Optimal control of interferon-γ and tumor necrosis factor αby interleukin 10 produced in response to HLA-DR mismatch during the primary mixed lymphocyte reaction. Transplantation 61:497
43. Treon SP, Anand B, Ulevitch R, Broitman SA (1994) CD14 mediated endogenous TNF-alpha release in HL60 AML cells: a potential model for CD14 mediated endogenous cytokine release in the treatment of AML. Leukemia Res 18:17
44. Wiernik PH, Dutcher JP, Todd M, Caliendo G, Benson L (1994) Polyethylene glycolated interleukin 2 as maintenance therapy for acute myelogenous leukemia in second remission. Am J Hematol 47:41